Key Sessions
Scott Schobel
Global Development Programme of RG6042, an Antisense Oligonucleotide, for the Treatment of Huntington’s Disease
F. Hoffman-La Roche Ltd.
David Craik, PhD
Plants as Biofactories for Producing Peptide-based Pharmaceuticals
University of Queensland
Ralf Wagner
Regulatory Quality and CMC Perspectives on mRNA Vaccines and Peptide Vaccine Adjuvants
Paul-Ehrlich-Institut